Year None2021202020192018201720162015201420132012 04.11.2019 Ophthotech Obtains Exclusive Global License to AAV Gene Therapy Program for BEST1 Related Retinal Diseases 03.14.2019 Ophthotech to Present at the Alliance for Regenerative Medicine’s (ARM) 7th Annual Cell & Gene Therapy Investor Day 03.06.2019 Ophthotech to Present at the Cowen and Company 39th Annual Health Care Conference 02.26.2019 Ophthotech Reports Fourth Quarter and Full Year 2018 Financial and Operating Results 02.19.2019 Ophthotech Corporation to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, February 26, 2019 01.03.2019 Ophthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference 01.02.2019 Ophthotech Announces the Addition of Ophthalmic Industry Leader, Calvin (Cal) W. Roberts, M.D., to Its Board of Directors 12.12.2018 Ophthotech Announces the Addition of Ophthalmic Industry Leader, Adrienne L. Graves, Ph.D., Former Chief Executive Officer of Santen Inc., to Its Board of Directors 11.12.2018 Ophthotech Announces Results from Phase 2a Safety Trial of Zimura® in Combination with Lucentis® in Wet Age-Related Macular Degeneration 10.31.2018 Ophthotech Reports Third Quarter 2018 Financial and Operating Results Pagination First page « first Previous page ‹ previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page next › Last page last »